Researcher

My Expertise

Epidemiology and cost effectiveness (economic evaluation) of infectious disease prevention.

Keywords

Fields of Research (FoR)

Health economics, Health Economics, Simulation and Modelling, Applied Mathematics, Infectious Diseases, Applied Economics, Biostatistics, Health Economics

SEO tags

Biography

Dr Anthony Newall is a health economist and Associate Professor in Health Economics at the School of Population Health, UNSW Sydney. He specialises in vaccine economics, particularly economic evaluation and cost-effectiveness analysis of vaccination and other infectious disease prevention strategies. He leads multidisciplinary research drawing on methods from health economics, mathematical modelling, epidemiology and statistics to address...view more

Dr Anthony Newall is a health economist and Associate Professor in Health Economics at the School of Population Health, UNSW Sydney. He specialises in vaccine economics, particularly economic evaluation and cost-effectiveness analysis of vaccination and other infectious disease prevention strategies. He leads multidisciplinary research drawing on methods from health economics, mathematical modelling, epidemiology and statistics to address policy questions in Australia and internationally.

He has authored more than 100 publications in peer-reviewed journals (h-index of 40, Google Scholar 2026) and has been an investigator on research grants totalling more than A$11.5 million. Based on publications indexed in Scopus (2026), he has published more articles on vaccine economics than any other Australian-based researcher, and his publication record is among the most extensive in the field internationally. His research spans a wide range of infectious diseases, including influenza, pneumococcal disease, rotavirus, COVID-19 and respiratory syncytial virus. His methodological interests include integrating economic evaluation with dynamic transmission models and equity-informative economic evaluation.

Anthony was the lead author of the World Health Organization (WHO) Guidance on the economic evaluation of influenza vaccination and co-authored the companion WHO Manual for estimating the economic burden of seasonal influenza. He has also served on the WHO Technical Advisory Group for the Full Value of Improved Influenza Vaccine Assessment (FVIVA), which examined the potential public health, economic and societal value of improved seasonal influenza vaccines. He was previously appointed to the WHO Roster of Experts in Health Economics.

He also has substantial experience contributing economic evidence to Australian vaccine policy. He led a Department of Health-commissioned cost-effectiveness review of pneumococcal vaccination for the National Immunisation Program that informed major changes to Australia’s national pneumococcal vaccination policy. He has presented to the Australian Technical Advisory Group on Immunisation (ATAGI) on vaccine economics questions on multiple occasions and served as a guest discussant for the Economics Sub-Committee of the Pharmaceutical Benefits Advisory Committee (PBAC).

He leads the health economics and economic evaluation research stream within UNSW’s Infectious Disease Dynamics and Interventions Group. He co-founded and is a convener of the Australian Health Economics Society Special Interest Group on the Economics of Infectious Diseases. He has also been a Visiting Associate Professor at Columbia University, a Visiting Scholar at the US National Institutes of Health, and an Honorary Fellow at the National Centre for Immunisation Research and Surveillance (NCIRS).

Anthony holds a Master of Public Health (Honours) and a PhD from the University of Sydney, where his PhD research focused on the cost-effectiveness of vaccination. His awards include the Bernie J. O’Brien New Investigator Award from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Aileen Plant Memorial Prize and the UNSW Faculty of Medicine Dean’s Rising Star Award.

He welcomes enquiries about research and policy collaborations in vaccine economics and the economic evaluation of infectious disease prevention. Prospective PhD students interested in projects in health economics, mathematical modelling, statistical analysis or epidemiology are welcome to contact him by email. Available PhD projects generally require strong quantitative skills, although other projects may be available for prospective undergraduate or Master’s students.


My Research Supervision


Supervision keywords

View less

Research Activities

This project will develop a novel framework for assessing the value for money achieved by childhood vaccination programs. This will provide decision makers with methodologically sound economic assessments that incorporate real world program outcomes